BROOKE WRIGHT: Open Payments
NPI 1861902652 · GAINESVILLE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$677 in 30 payments from 8 companies in 2025. Trend: 2023 $0 · 2024 $665 · 2025 $677
Food & beverage: $677
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $198 |
| Teva Pharmaceuticals USA, Inc. | 11 | $180 |
| Janssen Pharmaceuticals, Inc | 3 | $71 |
| Axsome Therapeutics, Inc. | 4 | $63 |
| Neurocrine BioSciences, Inc. | 2 | $54 |
| Vanda Pharmaceuticals Inc. | 2 | $52 |
| Alkermes, Inc. | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
Products named: CAPLYTA, UZEDY, Auvelity, INVEGA SUSTENNA, INGREZZA, FANAPT, AUSTEDO XR, LYBALVI.
Industry payments across FL — which companies pay providers there.
